Gorr, Ingo H.
Roche Pharma AG (Germany)
2 papers on CoChatORCID 0000-0003-0046-6452
Most cited papers
- Verified
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 1,384
- Verified
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Klein, C., Waldhauer, I., Nicolini, V. G., Freimoser-Grundschober, A., Nayak, T., Vugts, D. J., Dunn, C., Bolijn, M., Benz, J., Stihle, M., et al. (2017) · OncoImmunology
Monoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers
Cited by 281
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free